|Videos|March 31, 2022

A Role for Single Agent TKI Therapies in Treating Renal Cell Carcinoma

Oncologists debate whether TKI monotherapy has a place in renal cell carcinoma treatment after the CLEAR trial.

Episodes in this series


Latest CME